Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease
Condition: Wilson Disease Interventions: Drug: ALXN1840; Drug: Standard of Care Sponsor: Alexion Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials